Tech Transfer Roundup: Roivant Taps Research Labs For New Gene Therapies

 
• By Joseph Haas

In tandem with Roivant, Cincinnati Children’s launches spinout Aruvant focused on hematologic disorders and separately teams with BridgeBio on genetic disease therapies. Roivant spinout Axovant licenses gene therapy candidates from University of Massachusetts.

Tech Transfer regular column feature image

More from Strategy

More from Business